Second Sight Medical Products Inc (NASDAQ:EYES) announced that the Argus® II Retinal Prosthesis System (Argus II) has been implanted in the first patient …
Second Sight Medical Products Inc (NASDAQ:EYES) announced that the German Institute for the Hospital Remuneration System (InEK) has renewed Status 1 (full approval) …
Second Sight Medical Products Inc (NASDAQ:EYES) announced it filed a registration statement on Form S-1 with the Securities and Exchange Commission or a …
Second Sight Medical Products Inc (NASDAQ:EYES) announced, following a positive recommendation from advisors to the UK Government’s healthcare funding authority for specialized services …
In a research report published Wednesday, H.C.
Second Sight Medical Products Inc (NASDAQ:EYES) announced the first successful implantation and activation of a wireless visual cortical stimulator in a human subject, providing …
In a research report released Friday, Rodman & Renshaw analyst Amit Dayal reiterated a Buy rating on shares of Second Sight Medical Products Inc (NASDAQ:EYES), …
by Sonya Colberg Two eye-opening announcements over the last couple of days jumped shares of Second Sight Medical Products Inc (NASDAQ:EYES) above $6 …
Second Sight Medical Products Inc (NASDAQ:EYES), a developer, manufacturer and marketer of implantable visual prosthetics to provide some useful vision to blind patients, announced …
Second Sight Medical Products Inc (NASDAQ:EYES), a developer, manufacturer and marketer of implantable visual prosthetics to provide some useful vision to blind patients, …